University of Washington Medical Center

Research CenterTreats Aortic, Mitral, and Tricuspid valves

AI Description

The University of Washington Structural Heart Program provides multidisciplinary care from interventional cardiologists, cardiac surgeons, and advanced imaging specialists for complex valve disease. Treatments include transcatheter aortic valve replacement, mitral valve repair and replacement, tricuspid valve repair, paravalvular leak closure, and selected surgical aortic valve repairs.

This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information

Location and Contact

1959 Ne Pacific St Box 356151
Seattle, WA 98195

Clinical Trials

Recruiting

ARTIST

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

Public sites
32
Start date
Jun 18, 2025
Recruiting

ATLAS

ATLAS (AltaValve) Pivotal Trial

Public sites
30
Start date
Sep 3, 2024
Active, not recruiting

EARLY TAVR

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

Public sites
66
Start date
Jul 12, 2017
Recruiting

TANDEM II

EFS of the DUO System for Tricuspid Regurgitation

Public sites
10
Start date
Aug 13, 2024
Active, not recruiting

P3

PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

Public sites
62
Start date
Mar 1, 2016
Recruiting

ENCIRCLE

The ENCIRCLE Trial

Public sites
52
Start date
Nov 12, 2020
Active, not recruiting

ALIGN-AR

The JenaValve ALIGN-AR Pivotal Trial

Public sites
29
Start date
May 22, 2020
Recruiting

APOLLO

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Public sites
71
Start date
Oct 23, 2017

Nearby Centers